Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
about
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseAnti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo.The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD).Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease.Salmeterol/fluticasone combination in the treatment of COPD.Is there a role for antiinflammatory treatment in COPD?Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
P2860
Q24199130-AD8459AD-45D2-42B3-B0E1-80935F665D44Q24202510-901E6814-BC98-4575-99D4-21213A4753D8Q33612529-4ACCD7D2-693E-4330-A4D3-43CDAF7FA8A9Q34256492-EBAF81EF-3939-4C5A-BBF8-BC5185F26BDCQ35747045-B9C201F2-5C31-46C0-978E-1685385497A3Q36714251-04EBD989-56E8-46B8-8B29-AE8C2FF4978CQ36956720-F8BA6C13-61D1-4962-8094-7F36CE618457Q37018817-F25A09F7-223F-48A4-9FF0-3D0D83C53A65Q37622935-575CF3BB-520E-4876-97E6-221418DC7BFFQ47924133-DB8B6326-FEE2-49B3-8B21-2B48D540E428
P2860
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Can inhaled fluticasone alone ...... controlled trial [NCT00120978]
@nl
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@ast
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@en
type
label
Can inhaled fluticasone alone ...... controlled trial [NCT00120978]
@nl
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@ast
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@en
prefLabel
Can inhaled fluticasone alone ...... controlled trial [NCT00120978]
@nl
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@ast
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@en
P2093
P2860
P356
P1476
Can inhaled fluticasone alone ...... ontrolled trial [NCT00120978].
@en
P2093
ABC (Advair, Biomarkers in COPD) Investigators
Darcy D Marciniuk
Dave Williams
Eric Wilde
Ernest York
Gordon Ford
Lyle S Melenka
Mark FitzGerald
P2860
P2888
P356
10.1186/1471-2466-6-3
P407
P577
2006-02-06T00:00:00Z
P5875
P6179
1043085208